OBX OBX
Company Profile ↓Company Overview
OBX (OBX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 37.8%, reflecting efficient use of shareholder capital.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +62.91% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | - |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 37.8%.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | 91.25M | 105.67M |
| Operating Income | -91.25M | -105.67M |
| EBITDA | -89.73M | -104.18M |
| Interest Expense | - | - |
| Pretax Income | -83.11M | -100.61M |
| Tax Provision | 0 | 0 |
| Net Income | -83.11M | -100.61M |
| Diluted EPS | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Total Assets | 183.71M | 88.58M |
| Current Assets | 172.85M | 81.52M |
| Cash & Equivalents | 49.76M | 40.41M |
| Inventory | - | - |
| Receivables | - | - |
| Total Liabilities | 358.14M | 354.62M |
| Current Liabilities | 16.09M | 15.36M |
| Long Term Debt | - | - |
| Total Debt | 6.81M | 4.28M |
| Total Equity | -174.43M | -266.04M |
| Shares Outstanding | - | - |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating Cash Flow | -75.00M | -90.39M |
| Investing Cash Flow | -53.87M | 81.02M |
| Financing Cash Flow | 162.51M | 20.00K |
| Capital Expenditure | -779.00K | -73.00K |
| Free Cash Flow | -75.78M | -90.47M |
| Net Change in Cash | 33.64M | -9.36M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Gross Margin % | - | - |
| Operating Margin % | - | - |
| Net Margin % | - | - |
| ROE % | 47.6% | 37.8% |
| ROCE % | -54.4% | -144.3% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for OBX
Obsidian Therapeutics (OBX) Stock Trends and Sentiment 2026 $OBX - MarketBeat
<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE9GSzFkc090LWJtWnVfMEVwLVlqcGZRVTJiNUp3QTVWYTB2cGtDeTJWUFIxWXRicXN5VzBHUWNkX2ZDbUhLNzJEeDJzWlgyYnM2aXpDV3dSRDBCT05GcXRCU0RUQVZDTUJWakxRZlotYjh4UkNM?oc=5" target="_blank">Obsidian Th…
Norway stocks lower at close of trade; Oslo OBX down 0.35% - Investing.com
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPU3dHNVRFY0JkZXZfWjFfTl85N0xycHBxNVFXS01VSWFybDE1ZW9DNzlUa2lEVVVSc3ZMTEdwQ1ZSckJ4MldoRXlPdmhhdGtUOHVUVElQSDFQSFRaV0l5VkIwT0hmdTdQT1hPT3ZaV3NLVXFyM2pLMzlfQzJIVWxrd1JkT3hxS2QtTnFSdn…
Debt to assets ratio of Obsidian Therapeutics, Inc. – NASDAQ:OBX - TradingView
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNNmdVYkxMMFc5NWcxQ0d1VWk4ZHVrS2wxN29PYk1kWV96LUFEYlV3RUUtYTBlRU81dFVMNVo1SDc0Z29QSjhMTWVPZFJjeU9qUkNuS0Y3WWJfbVFSYkI4YzU5c1VpNklwN29ZT29lQk9kYzUzXzdZR1gtVDdZZEx1aXVMMHBfV293c0pRZW…
Obsidian Therapeutics (OBX) Stock Price, News & Analysis - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE5fSldwOTZkdk9tQnZzWEx4SXcxWDJTTGcyWVIwUThLT25Rd1B2dm5kejVLTG1yMG5iQ2YwSm1qNEt1VmhSX2oxU1lLczFOcWxZblE?oc=5" target="_blank">Obsidian Therapeutics (OBX) Stock Price, News & Analysis…
Obsidian Therapeutics (OBX) Stock Chart and Price History 2026 $OBX - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5YUWlGQTJ5Smw3NWt0alliNFJKdVkydE9VaUZXQ0xna2dUeEJlSnJlZmEwc2F2dXVTQWIwc2tkbXhGNnc5N3hSRXAyT0d4MGhFazFCLWxpQ2hkSWdTYm94cA?oc=5" target="_blank">Obsidian Therapeutics (OBX) Stock Cha…
About $350M is expected to fund Obsidian into 2028 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNUHZkX3RCYWRETzBsSnRGdi1jTlFKZWVnYzhId2VJZGo4LXZiUE9VeXlobEJvUllvNmFiOFFZRzdqZ3RwY2RNZU1CVlJrOHVVQzlORlRQMzBJNG1TN01YdjlzaVRfMnZRZDZJbmFHN0E3WEstc2IzbXhfbW1QUWIzX2VjNEZKMU5mc0trTk…
OBX — Frequently Asked Questions
What is the current share price of OBX?
As of 2026-08-05 17:25 PDT, OBX trades at $28.51 on NASDAQ/NYSE. Its 52-week range is $15.57 to $34.00.
What is the return on equity (ROE) of OBX?
OBX has a return on equity (ROE) of 37.82%. Its return on capital employed (ROCE) is -144.32%.
Is OBX a good stock to buy?
This page provides a data-driven analysis of OBX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.